The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease
Open accessAbstract
Our objective was to estimate the strength of the effect of the I148M (rs738409 C/G) patatin-like phospholipase domain containing 3 ( PNPLA3) variant on nonalcoholic fatty liver (NAFLD) and disease severity across different populations. We performed a systematic review by a meta-analysis; literature searches identified 16 studies. Our results showed that rs738409 exerted a strong influence not only on liver fat accumulation (GG homozygous showed 73% higher lipid fat content when compared with CC ones, data from 2,937 subjects; P < 1 × 10−9), but also on the susceptibility of a more aggressive disease (GG homozygous had 3.24-fold greater risk of higher necroinflammatory scores and 3.2-fold greater risk of developing fibrosis when compared with CC homozygous; P < 1 × 10−9; data from 1,739 and 2,251 individuals, respectively). Nonalcoholic steatohepatitis (NASH) was more frequently observed in GG than CC homozygous (odds ratio [OR] 3.488, 95% confidence interval [CI] 1.859–6.545, random model; P < 2 × 10−4; data from 2,124 patients). Evaluation of the risk associated with heterozygosity for the variant suggests that the additive genetic model best explains the effect of rs738409 on the susceptibility to develop NAFLD. Nevertheless, carrying two G alleles does not seem to increase the risk of severe histological features. Meta-regression showed a negative correlation between male sex and the effect of rs738409 on liver fat content (slope: −2.45 ± 1.04; P < 0.02). The rs738409 GG genotype versus the CC genotype was associated with a 28% increase in serum alanine aminotransferase levels. Conclusion: By summarizing the amount of evidence, this study provided unequivocal evidence of rs738409 as a strong modifier of the natural history of NAFLD in different populations around the world. (HEPATOLOGY 2011;)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302
Lohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S., & Hirschhorn, J. N. (2003) · Nature Genetics · doi:10.1038/ng1071 · Cited by 1,900
AGA technical review on nonalcoholic fatty liver disease
Sanyal, A. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36572 · Cited by 1,072
Valenti, L., Al‐Serri, A., Daly, A. K., Galmozzi, E., Rametta, R., Dongiovanni, P., Nobili, V., Mozzi, E., Roviaro, G., Vanni, E., et al. (2010) · Hepatology · doi:10.1002/hep.23622 · Cited by 651
He, S., McPhaul, C., Li, J. Z., Garuti, R., Kinch, L., Grishin, N. V., Cohen, J. C., & Hobbs, H. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.064501 · Cited by 610
Assessment of cumulative evidence on genetic associations: interim guidelines
Ioannidis, J. P., Boffetta, P., Little, J., O'Brien, T. R., Uitterlinden, A. G., Vineis, P., Balding, D. J., Chokkalingam, A., Dolan, S. M., Flanders, W. D., et al. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dym159 · Cited by 552
Estrogen Regulation of Adiposity and Fuel Partitioning
D'Eon, T. M., Souza, S. C., Aronovitz, M., Obin, M. S., Fried, S. K., & Greenberg, A. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507339200 · Cited by 517
Rotman, Y., Koh, C., Zmuda, J. M., Kleiner, D. E., & Liang, J. T. (2010) · Hepatology · doi:10.1002/hep.23759 · Cited by 475
Yuan, X., Waterworth, D., Perry, J. R. B., Lim, N., Song, K., Chambers, J. C., Zhang, W., Vollenweider, P., Stirnadel, H., Johnson, T., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.09.012 · Cited by 450
A feed-forward loop amplifies nutritional regulation of PNPLA3
Huang, Y., He, S., Li, J. Z., Seo, Y.-K., Osborne, T. F., Cohen, J. C., & Hobbs, H. H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003585107 · Cited by 386 · cited 1×
“Despite the explanation on the gene by sex interaction cannot be given by the present study, some evidence exists that the PNLPA3 gene is under the control of several factors, for instance, nutritional control in close relationship with SREBP-1c and liver X receptor.(27) Interestingly, sexual hormones, like estrogen,…”
BackgroundSookoian, S., Castaño, G. O., Burgueño, A. L., Gianotti, T. F., Rosselli, M. S., & Pirola, C. J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.p900013-jlr200 · Cited by 370
Self-citationGI Epidemiology: nonalcoholic fatty liver disease
ANGULO, P. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03246.x · Cited by 369
Speliotes, E. K., Butler, J. L., Palmer, C. D., Voight, B. F., & Hirschhorn, J. N. (2010) · Hepatology · doi:10.1002/hep.23768 · Cited by 362 · cited 3×
“Genotyping for rs738409 was carried out across studies using Taqman assay in 11(1,5,6,17-24) studies, by allele-specific oligonucleotides in two studies,(2,15) and by Sequenom MassARRAY iPLEX Gold platform (Sequenom, San Diego, CA) in the remaining three studies.(3,4,25) Fatty Liver Disease and Liver Fat Content.”
BackgroundMethodResultChalasani, N., Guo, X., Loomba, R., Goodarzi, M. O., Haritunians, T., Kwon, S., Cui, J., Taylor, K. D., Wilson, L., Cummings, O. W., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.057 · Cited by 315
Kantartzis, K., Peter, A., Machicao, F., Machann, J., Wagner, S., Königsrainer, I., Königsrainer, A., Schick, F., Fritsche, A., Häring, H.-U., et al. (2009) · Diabetes · doi:10.2337/db09-0279 · Cited by 303
Valenti, L., Alisi, A., Galmozzi, E., Bartuli, A., Del Menico, B., Alterio, A., Dongiovanni, P., Fargion, S., & Nobili, V. (2010) · Hepatology · doi:10.1002/hep.23823 · Cited by 291
Kotronen, A., Johansson, L. E., Johansson, L. M., Roos, C., Westerbacka, J., Hamsten, A., Bergholm, R., Arkkila, P., Arola, J., Kiviluoto, T., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1285-z · Cited by 290
Santoro, N., Kursawe, R., D'Adamo, E., Dykas, D. J., Zhang, C. K., Bale, A. E., Calí, A. M., Narayan, D., Shaw, M. M., Pierpont, B., et al. (2010) · Hepatology · doi:10.1002/hep.23832 · Cited by 218
Romeo, S., Sentinelli, F., Dash, S., Yeo, G. S. H., Savage, D. B., Leonetti, F., Capoccia, D., Incani, M., Maglio, C., Iacovino, M., et al. (2010) · International Journal of Obesity · doi:10.1038/ijo.2009.216 · Cited by 208
Davis, J. N., Lê, K.-A., Walker, R. W., Vikman, S., Spruijt-Metz, D., Weigensberg, M. J., Allayee, H., & Goran, M. I. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.30185 · Cited by 204
Hotta, K., Yoneda, M., Hyogo, H., Ochi, H., Mizusawa, S., Ueno, T., Chayama, K., Nakajima, A., Nakao, K., & Sekine, A. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-172 · Cited by 174
The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life
Romeo, S., Sentinelli, F., Cambuli, V. M., Incani, M., Congiu, T., Matta, V., Pilia, S., Huang-Doran, I., Cossu, E., Loche, S., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.02.034 · Cited by 162
Effects of PNPLA3 on Liver Fat and Metabolic Profile in Hispanic Children and Adolescents
Goran, M. I., Walker, R. W., Lê, K., Mahurkar‐Joshi, S., Vikman, S., Davis, J. N., Spruijt‐Metz, D., Weigensberg, M. J., & Allayee, H. (2010) · Diabetes · doi:10.2337/db10-0554 · Cited by 123
Metabolic Syndrome: From the Genetics to the Pathophysiology
Sookoian, S., & Pirola, C. J. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0164-9 · Cited by 102
Self-citationLin, Y., Chang, P., Hu, F., Yang, W., Chang, M., & Ni, Y. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.11.016 · Cited by 95
Wagenknecht, L. E., Palmer, N. D., Bowden, D. W., Rotter, J. I., Norris, J. M., Ziegler, J., Chen, Y. I., Haffner, S. M., Scherzinger, A. L., & Langefeld, C. D. (2011) · Liver International · doi:10.1111/j.1478-3231.2010.02444.x · Cited by 88
Sookoian, S., Gianotti, T. F., González, C. D., & Pirola, C. J. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000254372.88488.a9 · Cited by 86
Self-citationPolymorphisms in the adiponutrin gene are associated with increased insulin secretion and obesity
Johansson, L. E., Lindblad, U., Larsson, C., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0426 · Cited by 85
Specifically PNPLA3-Mediated Accumulation of Liver Fat in Obese Patients with Type 2 Diabetes
Petit, J., Guiu, B., Masson, D., Duvillard, L., Jooste, V., Buffier, P., Terriat, B., Bouillet, B., Brindisi, M., Loffroy, R., et al. (2010) · Endocrinology · doi:10.1210/endo.151.10.9996 · Cited by 51
Cited by
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Buzzetti, E., Pinzani, M., & Tsochatzis, E. A. (2016) · Metabolism · doi:10.1016/j.metabol.2015.12.012 · Cited by 3,119
Vernon, G., Baranova, A., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,074
Non-alcoholic fatty liver disease - a global public health perspective
Younossi, Z. M. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.033 · Cited by 2,149
Boursier, J., Mueller, O., Barret, M., Machado, M., Fizanne, L., Araujo‐Perez, F., Guy, C. D., Seed, P. C., Rawls, J. F., David, L. A., et al. (2016) · Hepatology · doi:10.1002/hep.28356 · Cited by 1,483
“2-fold higher risk of developing liver fibrosis (LF).((3)) Several other factors that influence the course of the disease have been identified, such as epigenetics,((4)) hormonal status,((5)) or nutrition.”
Background
Metadata
- Authors
- Sookoian, S., & Pirola, C. J.
- Venue
- Hepatology
- Published
- 2011-06
- Volume
- 53
- Issue
- 6
- Pages
- 1883-1894
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2071991978
- Cited by
- 920
- References
- 33
- FWCI
- 7.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.